PRMT5 and neuroblastoma: Given the MNA neuroblastoma-specific inhibition spectrum exhibited by GSK3203591 and the addiction of MNA neuroblastoma to glutamine [32,77], the convergence of DEGs and DSGs on genes in this pathway strongly supports the premise that PRMT5 contributes to the metabolic fitness of MNA neuroblastoma via augmenting glutamine metabolism.